Since schizophrenia is primarily considered a disorder of dopamine signaling, much of the evidence linking the cAMP pathway with schizophrenia is described within the context of D1 or D2 dopamine receptor activation (Wang et al., 2018). This evidence concerns the gene DRD2 and schizophrenia.